http://www.xerispharma.com
Xeris Pharmaceuticals, Inc. Company Intro
Xeris offers a novel formulation technology to bring ready-to-use, liquid-stable injectables to patients to remove many associated treatment burdens.
Industry
Healthcare
Xeris Pharmaceuticals, Inc. Headquaters
180 North LaSalle Street
Chicago,60601
United States
Xeris Pharmaceuticals, Inc. Share price
15 Jan 2021 02:52 GMT
$5.75
0.0 (0.0 %)
Xeris Pharmaceuticals, Inc. Market cap
$281.125 M
WMC RANKING
2021
Xeris Pharmaceuticals, Inc. # 233
BiotechnologyLatest Xeris Pharmaceuticals, Inc. News
08 Jan 2021
Xeris Pharmaceuticals, Inc. (NASDAQ:XERS) Drops -23.45 ...
Xeris Pharmaceuticals, Inc. (NASDAQ:XERS)'s traded shares stood at 3,538,864 during the last session, with the company's beta value hitting 0. At the close of ...
08 Jan 2021
Bullish Prospects For Xeris Pharmaceuticals, Inc. (NASDAQ:XERS) Shares In 2021
Xeris Pharmaceuticals, Inc. (NASDAQ:XERS) price on Friday, Jan 08, rose 2.93% above its previous day's close as an upside momentum from buyers pushed ...
08 Jan 2021
Xeris Pharmaceuticals, Inc. (NASDAQ:XERS) Drops -23.45 ...
Xeris Pharmaceuticals, Inc. (NASDAQ:XERS)'s traded shares stood at 3,538,864 during the last session, with the company's beta value hitting 0. At the close of ...
WMC Market Score
WMC Market to Revenue Score
Xeris Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Xeris Pharmaceuticals, Inc. | USD | $2,722 | $123,499 | $-125,580 | $2,811M | 233 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $552,640B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $342,630B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $588,000B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $279,490B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Xeris Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
Xeris Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
Xeris Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Xeris Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Xeris Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Xeris Pharmaceuticals, Inc. | 0.03 | 1.32 | 0.42 | 0 | 0 | 0 | 0.89 |
| Regeneron Pharmaceuticals, Inc. | 100 | 65.98 | 28.72 | 100 | 0 | 0 | 100 |
| Alexion Pharmaceuticals, Inc. | 63.42 | 16.08 | 100 | 60 | 0 | 0 | 90.49 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 8.81 | 86 | 0 | 0 | 99.97 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
